Therefore, the expression of FAM83A and B was analyzed in tumor tissue of NSCLC patients with ADC expressing either wild-type EGFR (79 patients) or EGFR signaling activating mutations (29 patients, Table 4). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.